3 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 1 | Unknown 1 |
Follow Diabetes Type 2: new trials by email Literature Review of Diabetes Type 2 trials Research Report on Diabetes Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH MET409 Active, MET409 Placebo, Empagliflozin - NASH, NASH - Nonalcoholic Steatohepatitis | Phase 2 | Unknown | Metacrine, Inc. | 120 | 2020-12-15 | 2021-06-01 |
| The Efficacy of Bariatric Surgery Compared to Medical Therapy in Controlling Type2 Diabetes Mellitus in Patients With Non Morbid Obesity. Laparoscopic Sleeve Gastrectomy, Laparoscopic Roux-en-Y Gastric Bypass, Advanced Medical Therapy - Overweight, Diabetes Type 2 | Phase 2 / Phase 3 | Unknown | Hadassah Medical Organization | 76 | 2015-01-01 | 2019-03-01 |
| ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) ARA 290 - Diabetes Type 2, Impaired Glucose Tolerance | Phase 2 | Unknown | Claes-Göran Östenson | 24 | 2013-10-01 | 2015-09-03 |
Diabetes Mellitus, Type 2 (3) · Diabetes Mellitus (2) · Fatty Liver (1) · Glucose Intolerance (1) · Inflammation (1) · Insulin Resistance (1) · Non-alcoholic Fatty Liver Disease (1) · Overweight (1)
Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Diabetes Mellitus (1) · Digestive System Diseases (1) · Hyperglycemia (1) · Hyperinsulinism (1) · Liver Diseases (1) · Nutrition Disorders (1) · Overnutrition (1) · Pathologic Processes (1) · Signs and Symptoms (1)
empagliflozin (1)
Claes-Göran Östenson (1) · Hadassah Medical Organization (1) · Metacrine, Inc. (1)
Israel (1) · Sweden (1) · United States (1)